Management of Elevated Ferritin in Obesity

Diagnostic Approach

The American Association for the Study of Liver Diseases recommends measuring transferrin saturation (TS) simultaneously with ferritin in obese patients—if TS is <45%, the elevated ferritin reflects inflammation from obesity-related metabolic dysfunction rather than iron overload, and no iron-directed therapy is indicated 1
When TS <45% and ferritin is elevated, this pattern indicates inflammatory hyperferritinemia, not iron overload, with over 90% of hyperferritinemia cases in outpatients due to inflammation, metabolic syndrome/NAFLD, alcohol consumption, cell necrosis, or malignancy—not hereditary hemochromatosis 1, 2
If TS ≥45% with elevated ferritin, proceed to HFE genetic testing (C282Y and H63D mutations) to evaluate for hereditary hemochromatosis 1, 3

The American College of Gastroenterology suggests treating the underlying metabolic condition, not the ferritin number itself, in cases of inflammatory hyperferritinemia 2, 5
Weight loss through caloric restriction and increased physical activity addresses the root cause of inflammation-driven ferritin elevation 6
Optimize glycemic control in diabetic patients, as diabetes is independently associated with higher ferritin levels even after controlling for BMI 1, 6
Manage NAFLD with lifestyle modification, as hepatic steatosis contributes to both ferritin elevation and metabolic dysfunction 1, 6

The European Association for the Study of the Liver recommends using complete iron profile (iron, TIBC, transferrin saturation, transferrin) rather than ferritin alone to accurately assess iron status in overweight and obese individuals 1
In patients with chronic kidney disease and obesity, ferritin 500-1,200 μg/L with TS <25% may represent functional iron deficiency that responds to IV iron therapy despite seemingly adequate ferritin levels 2, 5